Could Sedating Medications Be Making COVID-19 Outcomes Worse?


From HelloCare: “‘The benzodiazepines, especially, suppress respiratory function, so it makes sense if you have a primarily respiratory disease (such as COVID-19) and you’re taking medication that further depresses your ability to breathe, that’s going to worsen the outcome of someone affected with COVID-19 in residential care, or anywhere,’ [ Macfarlane] said.

Dr Macfarlane’s comments echo those of his colleague, Colm Cunningham, director of The Dementia Centre, who wrote recently about support for people living with dementia during the pandemic.

‘The use of medications that might cause respiratory depression or render a person immobile is likely to lead to an adverse outcome for that resident,’ he wrote.”


Support MIA

MIA relies on the support of its readers to exist. Please consider a donation to help us provide news, essays, podcasts and continuing education courses that explore alternatives to the current paradigm of psychiatric care. Your tax-deductible donation will help build a community devoted to creating such change.

Select Payment Method
Personal Info

Credit Card Info
This is a secure SSL encrypted payment.

Billing Details

Donation Total: $20 One Time


  1. I was under the impression the covid-19 virus interferes with the absorption mechanism of oxygen by the blood. It would explain why people who seem to be able to breathe normally still get tired very quickly when the virus is active. The oxygen is not entering the blood stream. It could also explain why diabetics are at higher risk.

    Report comment